Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang : Berdasarkan onset gejala, efek jangka panjang dari pascaCOVID-19 disebut long COVID. Long COVID berlangsung dari pekan keempat sampai lebih dari dua belas pekan paascaonset gejala. Selain gejala sisa COVID-19, hal yang harus dievaluasi adalah gambaran lesi paru sebagai sekuele pascaCOVID-19. Sekuele paru pascaCOVID-19 dievaluasi dengan high resolution computed tomography (HRCT). Sekuele paru pascaCOVID-19 yang dapat timbul adalah ground glass opacity dan gambaran fibrosis. Selain derajat berat COVID-19, banyak faktor yang memengaruhi terjadinya sekuele paru pascaCOVID-19. Penelitian ini bertujuan untuk mengetahui seberapa besar kekerapan terjadinya sekuele paru pascaCOVID-19 dan faktor-faktor yang memengaruhinya. Metode : Penelitian ini merupakan penelitian observasional analitik dengan pendekatan kohort yang dilakukan bulan Juni 2020 hingga Juli 2021. Subjek penelitian adalah pasien pascaCOVID-19 yang melakukan HRCT toraks pada pekan keempat hingga keduabelas dari onset gejala dengan hasil PCR usap tenggorok minimal satu kali negatif. Subjek penelitian dipilih sesuai kriteria inklusi dan eksklusi. Pengambilan data melalui data sekunder berupa data rekam medis dan hasil HRCT pasien yang kontrol di poli pascaCOVID RSUP Persabahatan. Hasil: Pada penelitian ini didapatkan total 81 subjek dengan pasien yang memiliki sekuele pascaCOVID-19 ada sebanyak 64 pasien dan yang tidak mengalami sekuele sebanyak 17 orang. Kelompok pasien yang mengalami sekuele paru pascaCOVID-19 paling banyak ada pada kelompok 40-59 tahun sebanyak 34 dari 41 pasien. Pada penelitian ini pasien laki-laki memiliki hubungan dengan terjadinya sekuele pascaCOVID-19 (p=0,002). Komorbid paling banyak dijumpai pada penelitian ini adalah hipertensi (54,3) dan DM tipe II (23,4%). Derajat COVID-19 berat kritis berhubungan terhadap terjadinya sekuele paru pascaCOVID-19 (nilai p 0,003). Kejadian ARDS juga memiliki hubungan dengan terjadinya sekuele paru pascaCOVID-19 (p=0,007). Pemakaian oksigen (O2) meliputi fraksi (p= 0,005) dan durasi (p= 0,006) juga memiliki hubungan yang bermakna dengan terjadinya sekuele paru pascaCOVID-19. Hasil analisis multivariat mendapatkan jenis kelamin dan derajat berat merupakan faktor-faktor yang memengaruhi sekuele paru pasca-COVID-19.

---

Background: The long-term effects of post-COVID-19 are known as long COVID based on the onset of symptoms. Long COVID lasts from the fourth week to more than twelve weeks after the onset of symptoms. In addition to the sequelae of COVID-19, what must be evaluated is the appearance of lung lesions as a sequelae after COVID-19. Post-COVID19 pulmonay sequelae was evaluated by high-resolution computed tomography (HRCT) as ground glass opacity and fibrosis. Beside COVID-19 severity, a variety of other factors have a role in the development of post-COVID-19 pulmonary sequelae. The purpose of this study is to determine the frequency of post-COVID-19 pulmonary sequelae and their influencing factors.

Methods: This study was an analytic observational study with a cohort approach that was conducted from June 2020 to July 2021. The subjects were post-COVID-19 patients who underwent thoracic HRCT in the fourth to twelfth week of symptom onset with a negative throat swab PCR result at least once. The inclusion and exclusion criteria were used to determine which subjects will be included in the study. Data collection through secondary data form medical record and HRCT results of patients controlled at the post-COVID polyclinic at Persahabatan Hospital.

Results: In this study, there were 64 patients who had post-COVID-19 sequelae and 17 patients who did not. There was a total of 81 subjects. The group of patients who experienced post-COVID-19 pulmonary sequelae was mostly in the 40-59 years group with 34 out of 41 patients. In this study, male patients had an association with post-COVID-19 sequelae (p=0.002). The most common comorbidities found in this study were hypertension (54.3) and type II DM (23.4%). The degree of critically severe COVID-19 is related to the occurrence of post-COVID-19 pulmonary sequelae (p 0.003). The incidence of ARDS also has a relationship with the occurrence of post-COVID-19 pulmonary sequelae (p=0.007). Oxygen consumption including fraction of inspired oxygen (p= 0.005) and duration (p= 0.006) also has a significant relationship with the occurrence of post-COVID-19 pulmonary sequelae. The results of the multivariate analysis found that gender and severity were factors that influenced post-COVID-19 pulmonary sequelae."

"Latar Belakang: Pneumocystis jirovecii (P. jirovecii) adalah patogen jamur oportunistik yang dapat terdeteksi di saluran napas bawah. Kolonisasi P. jirovecii dapat berkembang menjadi infeksi yang disebut sebagai pneumocystis pneumonia (PCP). Infeksi PCP umumnya terdeteksi di pasien HIV. Pasien tanpa HIV juga dapat mengalami infeksi PCP terutama pada pasien keganasan. Penelitian ini bertujuan untuk mendeteksi kolonisasi P. Jirovecii pada sampel bilasan bronkus dengan pemeriksaan polymerase chain reaction (PCR). Metode: Penelitian ini merupakan penelitian potong lintang dengan deskriptif analitik yang pada pasien terduga kanker paru di RSUP Persahabatan. Subjek penelitian adalah pasien terduga kanker paru yang akan menjalani bronkoskopi sesuai kriteria inklusi. Sampel bilasan bronkus dikirim ke Laboratorium Departemen Parasitologi FKUI untuk ekstraksi DNA dan laboratorium BRIN untuk pemeriksaan PCR konvensional. Penelitian ini menggunakan gen MtLSU dan mTSSU. Hasil: Pada penelitian ini terdapat 72 subjek penelitian. Subjek penelitian terdiri atas 51 laki-laki (70,8%). Rerata usia subjek penelitian adalah 56,6 (9,95) tahun. Subjek penelitian sebagian besar memiliki IMT normal (18,5-22,9 kg/m2). Subjek penelitian sebagian besar adalah perokok baik perokok aktif atau bekas perokok yaitu sebanyak 50 orang (69,4%). Sebanyak 23 orang (31,9%) diantaranya memiliki IB berat (IB >600 batang per tahun). Subjek penelitian yang memiliki riwayat pengobatan TB, baik terkonfirmasi bakteriologis maupun diagnosis klinis, sebanyak 23 orang (31,9%). Sebanyak 26 orang (36,1%) memiliki 1 komorbid sedangkan 10 orang (13,9%) memiliki lebih dari 1 komorbid. Berdasarkan pemeriksaan histopatologi atau sitologi bilasan bronkus, dari 72 subjek penelitian terdapat 50 orang (69,4%) terdiagnosis kanker paru, 15 orang (20,9%) bukan kanker paru, dan 7 orang (9,7%) belum diketahui diagnosisnya. Dari 72 sampel yang diperiksa, tidak ada yang menunjukan hasil PCR positif (0%). Kesimpulan: Proporsi P. Jirovecii yang terdeteksi melalui pemeriksaan PCR pada sampel bilasan bronkus pasien terduga kanker paru sebesar 0%. Pemeriksaan PCR untuk mendeteksi P. Jirovecii tidak disarankan untuk pasien kanker yang baru terdiagnosis dan belum dilakukan pengobatan.

---

Background: Pneumocystis jirovecii (P. jirovecii) is an opportunistic fungal pathogen that can be detected in the human lower respiratory tract without signs or symptoms of acute pneumonia or colonization. P. jirovecii colonization can develop into an infection known as pneumocystis pneumonia (PCP). PCP infection is commonly detected in HIV patients. However, patients without HIV can also experience PCP infection, especially in malignant patients. This study aims to detect P. Jirovecii colonization in bronchial lavage samples using polymerase chain reaction (PCR). Methods: This research is a cross-sectional study with descriptive analytics on patients suspected of lung cancer at Persahabatan Hospital. The research subjects were patients with suspected lung cancer who were selected according to the inclusion criteria. Data on clinical, radiological, laboratory and histopathological characteristics were taken from medical records. The patient will have a bronchial lavage sample taken during bronchoscopy for diagnostic purposes. The samples will be examined at the Parasitology Department Laboratory Universitas Indonesia for DNA extraction and the BRIN laboratory for PCR examination. Results: In this study there were 72 research subjects. The research subjects consisted of 51 men (70.8%). The mean age of the research subjects was 56.6 (9.95) years. Most of the research subjects had normal BMI (18.5-22.9 kg/m2). Most of the research subjects were smokers, either active smokers or former smokers, namely 50 people (69.4%). A total of 23 people (31.9%) had severe IB (IB >600 cigarettes per year). There were 23 research subjects who had a history of TB treatment, whether confirmed bacteriologically or clinically diagnosed, as many as 23 people (31.9%). A total of 26 people (36.1%) had 1 comorbid while 10 people (13.9%) had more than 1 comorbid. Based on histopathological or cytological examination of bronchial lavage, of the 72 research subjects, 50 people (69.4%) were diagnosed with lung cancer, 15 people (20.9%) had no lung cancer, and 7 people (9.7%) had no known diagnosis. Of the 72 samples examined, none showed positive PCR results (0%). Conclusion: The proportion of P. Jirovecii detected by conventional PCR examination in bronchial lavage samples from patients suspected of lung cancer was 0%. PCR examination to detect P. Jirovecii is not recommended for cancer patients who have just been diagnosed and have not received treatment."